ClinVar Miner

Submissions for variant NM_000038.6(APC):c.6525A>G (p.Thr2175=) (rs200151646)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000119189 SCV000153926 benign Familial adenomatous polyposis 1 2020-12-04 criteria provided, single submitter clinical testing
GeneDx RCV001310856 SCV000209478 likely benign not provided 2020-09-21 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 23709753, 28526081)
Ambry Genetics RCV000159521 SCV000214464 likely benign Hereditary cancer-predisposing syndrome 2015-01-01 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Illumina Clinical Services Laboratory,Illumina RCV000374754 SCV000452036 uncertain significance APC-Associated Polyposis Disorders 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000254629 SCV000600129 uncertain significance not specified 2016-07-05 criteria provided, single submitter clinical testing
Color Health, Inc RCV000159521 SCV000681805 likely benign Hereditary cancer-predisposing syndrome 2016-09-28 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000254629 SCV000918460 benign not specified 2017-10-31 criteria provided, single submitter clinical testing Variant Summary: The c.6525A>G (p.Thr2175Thr) variant involves the alteration of a non-conserved nucleotide resulting in a synonymous change. 4/5 in silico tools via Alamut predict the strengthening of a cryptic splice donor site as well as minor changes to other binding motifs, however, the significance of these predictions has not been supported with functional studies. The variant was observed in the general population dataset of gnomAD at an allele frequency of 0.00011 (32/275542 chromosomes tested), predominantly observed in the European (Non-Finnish) subpopulation at a frequency of 0.0002 (26/126026 chromosomes). This frequency exceeds the maximal expected allele frequency for a pathogenic variant in APC (0.00007) by 3-folds, strongly supporting that this is a benign polymorphism found primarily in population(s) of European origin. The variant has been reported once in the literature in a CRC patient without strong evidence for or against pathogenicity (Borras_2013). In addition, multiple clinical laboratories/reputable databases have classified the variant as likely benign. Taken together, this variant has been classified as benign.
CeGaT Praxis fuer Humangenetik Tuebingen RCV001310856 SCV001500826 likely benign not provided 2020-07-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.